Arcus Biosciences
RCUS
RCUS
148 hedge funds and large institutions have $1.16B invested in Arcus Biosciences in 2020 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 41 increasing their positions, 51 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 128 → 148 (+20)
0.3% more ownership
Funds ownership: 68.39% → 68.69% (+0.3%)
20% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 51
Holders
148
Holding in Top 10
4
Calls
$6.8M
Puts
$4.22M
Top Buyers
| 1 | +$35.7M | |
| 2 | +$21.7M | |
| 3 | +$10.1M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$10M |
| 5 |
Goldman Sachs
New York
|
+$7.9M |
Top Sellers
| 1 | -$18.1M | |
| 2 | -$14.4M | |
| 3 | -$10.1M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$9.43M |
| 5 |
Alkeon Capital Management
New York
|
-$7.99M |